David Barlam Consulting, Pearl St, Somerville, MA 02145, US

Selux Diagnostics is a Boston-based company that is revolutionizing antibiotic susceptibility testing (AST) with their proprietary Next Generation Phenotyping (NGP) System. Their innovative technology allows for rapid AST on all sample types, providing faster and more comprehensive results than traditional methods. With a commitment to updated breakpoints and a comprehensive bug drug menu, Selux is dedicated to combating antimicrobial resistance and preserving the effectiveness of antibiotics for future generations. By redefining speed and accuracy in AST, Selux is addressing the global health crisis of antimicrobial resistant infections. Their NGP System offers same-shift results, high throughput, and the ability to test against all commercially relevant antibiotics at one time. With a focus on patient care and antibiotic stewardship, Selux is on a mission to outsmart bacteria and ensure the continued efficacy of lifesaving antibiotics.Generated from the website